Carregant...
Overcoming Platinum Resistance in Ovarian Carcinoma
IMPORTANCE OF THE FIELD: Ovarian cancer remains a deadly malignancy because most patients develop recurrent disease that is resistant to chemotherapy, including platinum. Because response rates for current treatment regimens are relatively similar and unfortunately low, no standard chemotherapy for...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2962713/ https://ncbi.nlm.nih.gov/pubmed/20815774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.2010.515585 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|